# EDGAR Filing Document

**Accession Number:** 0000805928
**File Stem:** 0000805928-25-000095
**Filing Date:** 2025-6
**Character Count:** 7549
**Document Hash:** f1e50ba9fd175389fa0e8b05ea799085
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000805928-25-000095.hdr.sgml**: 20250620

**ACCESSION NUMBER**: 0000805928-25-000095

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20250618

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250620

**DATE AS OF CHANGE**: 20250620

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Axogen, Inc.
- **CENTRAL INDEX KEY:** 0000805928
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 411301878
- **STATE OF INCORPORATION:** MN
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36046
- **FILM NUMBER:** 251061303

**BUSINESS ADDRESS:**
- **STREET 1:** 13631 PROGRESS BLVD.
- **STREET 2:** SUITE 400
- **CITY:** ALACHUA
- **STATE:** FL
- **ZIP:** 32615
- **BUSINESS PHONE:** (386) 462-6817

**MAIL ADDRESS:**
- **STREET 1:** 13631 PROGRESS BLVD.
- **STREET 2:** SUITE 400
- **CITY:** ALACHUA
- **STATE:** FL
- **ZIP:** 32615

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AxoGen, Inc.
- **DATE OF NAME CHANGE:** 20111004

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LECTEC CORP /MN/
- **DATE OF NAME CHANGE:** 19920703

?xml version='1.0' encoding='ASCII'? axgn-20250618

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**Form 8-K**

**Current Report**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): June 18, 2025**

**AXOGEN, INC.**

**(**Exact Name of Registrant as Specified in Charter)

**Minnesota**

(State or Other Jurisdiction of

Incorporation or Organization)

**001-36046**

(Commission File Number)

**41-1301878**

(I.R.S. Employer Identification No.)

**13631 Progress Boulevard, Suite 400 Alachua, Florida**

(Address of principal executive offices)

**32615**

(Zip Code)

**(386) 462-6800**

(Registrant's telephone number, including area code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of exchange on which registered** |
| Common Stock, $0.01 par value | AXGN | The Nasdaq Stock Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 5.07. Submission of Matters to a Vote of Security Holders**

On June 18, 2025, Axogen, Inc. (the "Company") held its 2025 annual meeting of shareholders (the "Annual Meeting"), at which a total of 37,190,480 shares of common stock of the Company, out of a total 45,534,866 shares of common stock outstanding and entitled to vote as of April 23, 2025, the record date, were present in person or represented by proxies. The Company's shareholders voted on five proposals at the Annual Meeting. The proposals are described in detail in the proxy statement for the Annual Meeting that the Company filed with the Securities and Exchange Commission on April 30, 2025. The results of voting on the five proposals, including the final vote tabulations, are set forth below.

*Proposal 1: Election of Directors*

Eight directors were elected to the Company's Board of Directors to serve for a one-year term until the 2026 annual meeting of shareholders. The results of the election were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **Name** | **For** | **Withheld** | **Broker Non-Votes** |
| Paul Thomas | 30961354 | 1028894 | 5200232 |
| Michael Dale | 31257947 | 732301 | 5200232 |
| William Burke | 30707128 | 1283120 | 5200232 |
| John H. Johnson | 26774254 | 5215994 | 5200232 |
| Alan Levine | 31047002 | 943246 | 5200232 |
| Joseph Tyndall | 30741765 | 1248483 | 5200232 |
| Kathy Weiler | 30499131 | 1491117 | 5200232 |
| Amy Wendell | 30152102 | 1838146 | 5200232 |

---

*Proposal 2: Ratification of Appointment of Independent Auditors*

The Audit Committee's selection of Deloitte & Touche LLP as the Company's registered independent public accounting firm for the fiscal year ending December 31, 2025 was ratified. The results of the vote were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **For** | **Against** | **Abstentions** | **Broker Non-Votes** |
| &nbsp;&nbsp;37,035,398 | 36,082 | 119,000 |  |

---

*Proposal 3: Compensation of the Named Executive Officers*

The advisory (non-binding) vote on the executive compensation of the Company's named executive officers was approved. The results of the vote were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **For** | **Against** | **Abstentions** | **Broker Non-Votes** |
| 28,700,739 | 3,241,203 | 48,306 | 5,200,232 |

---

*Proposal 4: Amendment and Restatement of the Axogen, Inc. 2019 Long-Term Incentive Plan*

The Axogen, Inc. Fourth Amended and Restated 2019 Long-Term Incentive Plan to increase the number of shares reserved for issuance thereunder from 10,500,000 to 13,400,000 was approved. The results of the vote were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **For** | **Against** | **Abstentions** | **Broker Non-Votes** |
| 16,743,112 | 15,208,277 | 38,859 | 5,200,232 |

---

*Proposal 5: Frequency of Future Shareholders' Votes to Approve the Compensation of the Named Executive Officers*

The advisory (non-binding) vote on the frequency of future non-binding shareholders' votes to approve the compensation of the Company's named executive officers. The results of the vote were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **1 Year** | **2 Years** | **3 Years** | **Abstentions** | **Broker Non-Votes** |
| 31,095,988 | 20,797 | 785,255 | 88,208 | 5,200,232 |

---

------

**Item 9.01. Financial Statements and Exhibits**

(d) Exhibits

<u>Exhibit No.</u> <u>Description</u>

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

------

**SIGNATURES**

Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | AXOGEN, INC. | AXOGEN, INC. |
| Date: June 20, 2025 | By: | /s/ Marc Began |
|  |  | Marc Began |
|  |  | Executive Vice President, General Counsel and Chief Compliance Officer |

---